Image 1
Mefloquine Hydrochloride Tablet
Product Images NDC 0555-0171
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mefloquine Hydrochloride (NDC 0555-0171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
The text provides information on a medication called Mefloquine HCI in the form of tablets with a potency of 250 mg. It indicates the manufacturer, TEVA Pharmaceuticals in North Wales, PA, the NDC code (0555-0171-78), and that each tablet contains 250 mg of mefloquine hydrochloride USP. The text also mentions a Medication Guide that the pharmacist should dispense to each patient. There is a note about a Non-Varnished Area for Cading.*
Image 3
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
